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Abstract 
Severe cases after pH1N1 infection are consequence of interstitial pneumonia triggered by alveolar viral replication 
and an exacerbated host immune response, characterized by the up-regulation of pro-inflammatory cytokines and 
the influx of inflammatory leukocytes to the lungs. Different lung cell populations have been suggested as culprits in 
the unregulated innate immune responses observed in these cases. This study aims to clarify this question by study-
ing the different induction of innate immune molecules by the distinct lung anatomic compartments (vascular, alveo-
lar and bronchiolar) of ferrets intratracheally infected with a human pH1N1 viral isolate, by means of laser microdissec-
tion techniques. The obtained results were then analysed in relation to viral quantification in the different anatomic 
areas and the histopathological lesions observed. More severe lung lesions were observed at 24 h post infection (hpi) 
correlating with viral antigen detection in bronchiolar and alveolar epithelial cells. However, high levels of viral RNA 
were detected in all anatomic compartments throughout infection. Bronchiolar areas were the first source of IFN-α 
and most pro-inflammatory cytokines, through the activation of RIG-I. In contrast, vascular areas contributed with the 
highest induction of CCL2 and other pro-inflammatory cytokines, through the activation of TLR3.
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Introduction
In 2009, the swine-origin H1N1 influenza A virus (IAV) 
emerged and caused outbreaks of respiratory illness in 
humans around the world. After the 2009 pandemic, out-
breaks of that strain have continued to cause serious ill-
ness and increased mortality, particularly in young adults 
and children [1]. The physiopathology of pandemic H1N1 
(pH1N1) infection differs between individuals. Whilst 
most patients develop mild upper respiratory-tract infec-
tion [2], some patients progress to develop severe lower 
respiratory tract complications [3]. In addition, high rates 
of clinically unapparent infections have been reported by 
seroepidemiological studies [4, 5]. This evidence suggests 
that the severity of influenza is, at least, partially deter-
mined by host factors.
Severe cases after pH1N1 infection are consequence of 
diffuse alveolar damage (DAD) [3], also termed intersti-
tial pneumonia, triggered by the spread of pH1N1 infec-
tion from the upper to the lower respiratory tract [6, 7] 
and an exacerbated inflammatory host immune response 
[8–12]. Several hypotheses have been made about the 
mechanisms involved in the dysregulation of the host 
inflammatory response after pH1N1 and IAV infection. 
However, all of them involve the up-regulation of pro-
inflammatory cytokines [13, 14] and the influx of inflam-
matory leukocytes to the lungs [9, 15].
While leukocytes have traditionally been considered 
the major source of pro-inflammatory cytokines, there is 
also a consensus calling attention to the role of epithelial 
and endothelial cells as important sources of pro-inflam-
matory cytokines during various infectious processes 
[16–18]. In a recent study, Brandes et  al. [9] showed 
that lethality in a murine model of acute influenza arose 
directly from the damage caused by constrained innate 
inflammation primarily involving neutrophils co-acting 
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with monocytes. However, the first influx of neutrophiles 
and monocytes needs to be induced by the release of 
innate immune mediators from lung resident cell popu-
lations (respiratory epithelium, endothelium and alveolar 
macrophages), which first come in contact with the virus.
During pH1N1 infection, leukocyte influx into the 
lungs is regulated by the signalling effects of cytokines 
and chemokines released by different lung cell popu-
lations in response to infection [13, 14, 19]. Although 
cytokines have specific functions and are released in a 
cell-type-dependent manner, all of them are produced/
activated via common mechanisms involving the acti-
vation of pattern recognition receptors (PRRs) [20, 21]. 
By these means, several studies have implicated either 
lung endothelial or epithelial cells as key regulators in 
the initial release of pro-inflammatory cytokines after 
pH1N1 infection [10, 14, 16]. However, their relative 
contribution to cytokine release regulation mechanisms 
and the dynamics of their release have not entirely been 
elucidated.
Understanding which cellular types and inflamma-
tory dynamics are involved in the development of the 
detrimental inflammatory response after IAV infection, 
is important for the future development of therapeutic 
strategies, designed to the control of the host immune 
response. In this way, the modulation of the host immune 
response will have the potential advantage of exerting 
less selective pressure on viral populations, an impor-
tant factor in the development of IAV infection therapies. 
With the aim to unravel the mechanisms involved in the 
regulation of the innate immune response against IAV 
infection, and the relative contribution of the different 
lung compartments, we investigated the early induction 
of innate immune molecules, observed in different lung 
compartments. We tried to discern the cytokine pro-
duction of the main cell type present in each lung com-
partment (endothelial cells, epithelial bronchiolar cells 
and alveolar epithelial cells) by means of a laser capture 
microdissection (LCM) technique. As the limitations of 
the technique did not allow us to completely individual-
ize the target cells, we assessed the cytokine expression 
associated to the viral replication in the different lung 
compartments (vascular, alveolar and bronchiolar).
Materials and methods
Virus
The human pH1N1 isolate A/CastillaLaMancha/
RR5911/2009 was used in the present study. The virus 
was isolated at the National Influenza Centre, Centro 
Nacional de Microbiología, Instituto de Salud Carlos 
III (CNM, ISCIII) from a respiratory sample sent by the 
Spanish Influenza Surveillance System for virological 
characterization. It was isolated from a 35-years old 
woman, without co-morbidities, who developed a 
severe disease and died. The viral isolate was passaged in 
Madin-Darby Canine kidney (MDCK) cell cultures four 
times and had a final titre of 106.02 TCID50/mL. Titre was 
determined using the Reed and Muench method [22].
Ferrets
Eleven neutered male ferrets between 8 and 9  months 
of age, and seronegative for IAV (influenza A antibody 
competition multi-species ELISA, ID Screen®, France), 
were randomly selected from a stable, purposely bred 
colony (Euroferret, Denmark). Upon arrival at the Cen-
tre de Recerca en Sanitat Animal (CReSA), the animals 
were placed in biosafety level 3 (BSL-3) facilities. Fer-
rets were randomly assigned to different experimental 
groups, separated into experimental isolation rooms 
and then acclimated during 1  week. The animals were 
inhabited in standard housing cages for laboratory fer-
rets (F-SUITE Ferret Housing, Tecniplast, Italy) and 
they were provided with commercial food pellets and 
tap water ad  libitum throughout the experiment. All 
experiments were performed under a protocol (no. 
1976) that was reviewed and approved by the Animal 
and Human Experimentation Ethics Commission of 
the Universitat Autònoma de Barcelona. Animals were 
divided into two groups. The control group included 
two ferrets and the infected group included nine ferrets 
which were intratracheally inoculated with 105 TCID50/
mL of the A/CastillaLaMancha/RR5911/2009 virus 
diluted in 0.5 mL of phosphate buffer saline (PBS). Dur-
ing inoculation, animals were deep sedated with butor-
phanol (0.05  mg/kg) (Torbugesic® Vet, S.A., Spain) 
and medetomidine (0.05 mg/kg) (Domtor® Pfizer, S.A., 
Spain) administered subcutaneously. After inoculation, 
animals were reverted from sedation with atipamezole 
(0.25 mg/kg) subcutaneously administered and moni-
tored by a specialized veterinarian until complete recov-
ering from sedation. Control and infected animals were 
euthanized at 0 and 12, 24 and 72 h post infection (hpi) 
respectively. Early times post infection were selected 
in order to evaluate the innate immune response and 
assess early immune viral recognition and induction of 
pro-inflammatory cytokines and chemokines through-
out infection. Animals were euthanized by an intrave-
nous injection of sodium pentobarbital (100  mg/kg), 
under anaesthesia with ketamine (5–10  mg/kg) (Imal-
gene 1000® Merial, S.A., Spain) and medetomidine 
(0.05  mg/kg) (Domtor® Pfizer, S.A., Spain), adminis-
tered subcutaneously. Necropsies were performed in 
control and infected animals after euthanasia according 
to a standard protocol.
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Histopathology
Right lung lobe sections (cranial and caudal lobes), were 
taken for histological examination. The tissues were fixed 
for 24–48  h in neutral-buffered 10% formalin, and then 
embedded in paraffin wax in two different blocs contain-
ing one portion of the cranial and the caudal right lung 
lobes, consecutively taken. One of the paraffin blocks 
was sectioned at 3  µm, and stained with haematoxylin 
and eosin (HE) for examination under light microscopy; 
the second paraffin block was used for microdissection 
studies.
Cross sections of the cranial and caudal pulmonary 
lobes for each animal were histopathologically and 
separately evaluated. Semiquantitative assessment of 
IAV-associated microscopic lesions in the lungs was per-
formed. The lesional scoring was graded on the basis of 
lesion severity as follows: grade 0 (no histopathological 
lesions observed), grade 1 (mild to moderate necrotizing 
bronchiolitis), grade 2 (bronchointerstitial pneumonia 
characterised by necrotizing bronchiolitis and alveo-
lar damage in adjacent alveoli), and grade 3 (necrotizing 
bronchiolitis and diffuse alveolar damage in the major-
ity of the pulmonary parenchyma). Microscopic lesional 
scores were assigned for each lobe, and the means of the 
two lobes were used for the final histopathological score 
for each animal.
Laser capture microdissection
Lung samples from infected and control animals were 
used for the microdissection study. For each animal, 
20  μm sections were cut from formalin-fixed paraffin-
embedded (FFPE) lung tissue and mounted in PEN-
membrane slides (two sections per slide). Prior to 
deparaffinization, slides were placed into an oven at 
60  °C for 25  min. For each lung sample, sections were 
cut, deparaffinised, and rehydrated using standard pro-
tocols with RNase-free reagents, and stained with 1% 
cresyl violet acetate (SIGMA, C5042), and alcoholic 1% 
eosin (Alvarez, 10-3051). Stained slides were then dehy-
drated through a series of graded ethanol steps prepared 
with DEPC treated water (Ambion, P/N AM9915G) to 
100% ethanol. The slides were then air-dried for 10 min, 
and individually frozen at −80  °C in 50  mL parafilm 
sealed falcons, before being transferred to the LCM 
microscope (LMD6500; Leica Microsystems) for simple 
microdissection.
Bronchiolar, vascular, and alveolar areas were sepa-
rately selected for analysis using the Leica LMD6500 
(Leica) system (20× magnification, Laser Microdissec-
tion  6000 software version 6.7.0.3754). Selected areas 
were chosen by a pathologist as observed in Figure  1. 
In infected animals, areas which exhibited pathological 
lesions were preferably selected. The total dissected area 
per selected lung compartment and animal rose approxi-
mately to 1.5 mm2. One cap was used per anatomic dis-
sected compartment and animal.
The different dissected areas were then collected sep-
arately into RNAse-free 1.5  mL PCR tubes, per lung 
compartment.
Viral detection and quantification
Viral titration from lungs samples and nasal swabs was 
performed on control and infected animals, and deter-
mined by plaque forming units (PFU) as described 
previously [23]. A portion of around 0.2  g of the right 
caudal lung lobe and nasal swabs were placed in 0.5 mL 
of Dulbecco’s Modified Eagle’s Medium (DMEM) (Bio-
Whittaker®, Lonza, Verviers, Belgium) with 600  µg/mL 
penicillin and streptomycin, and frozen at −80  °C until 
further processing.
For the detection of IAV antigen by immunohistochem-
istry (IHC), paraffin sections were stained with a primary 
antibody against the influenza A nucleoprotein (NP), as 
previously described [8, 24]. Briefly, an antigen retrieval 
step was performed using protease XIV (Sigma-Aldrich, 
USA) for 10 min at 37 °C, and then blocked for 1 h with 
2% bovine serum albumin (BSA) (85040C, Sigma-Aldrich 
Química, S.A., Spain) at room temperature (RT). Sam-
ples were then incubated with a commercially available 
mouse-derived monoclonal antibody (ATCC, HB-65, 
H16L-10-4R5) concentration (343 mg/mL), as a primary 
antibody, at a dilution of 1:100 at 4 °C overnight, followed 
by 1 h incubation with biotinylated goat antimouse IgG 
secondary antibody (Dako, immunoglobulins As, Den-
mark). Finally, an ABC system (Thermo Fisher Scientific, 
Rockjord, IL, USA) was used and the antigen–antibody 
reaction was visualized with 3, 3′-diaminobenzidine 
DAB as chromogen. Sections were counterstained with 
Mayer’s haematoxylin. The positive control consisted 
of a FFPE lung from a ferret and of a FFPE heart from 
a chicken, experimentally infected with influenza. The 
same sections in which the specific primary antibody was 
substituted with PBS or an irrelevant antibody [anti-Por-
cine Circovirus type 2 (PCV2), diluted 1:1000] were used 
as negative controls. Semiquantitative assessments of 
IAV antigen expression in the lungs were performed. The 
positive cells in six arbitrarily chosen 20× objective fields 
in alveolar areas, and five arbitrarily chosen 20× objec-
tive fields in bronchial or bronchiolar areas, were quanti-
fied separately in each lung lobe (cranial and caudal) for 
every animal. The mean of the total cell counts per field 
across two lobes was calculated for each animal.
Viral RNA from total lung samples (proximal medias-
tinic right caudal lobe section of 5  mm2) was extracted 
with NucleoSpin® RNA Virus Kit (Macherey–Nagel, 
Düren, Germany), following the manufacturer’s 
Page 4 of 11Vidaña et al. Vet Res  (2016) 47:113 
instructions. IAV matrix (M) gene was then quantified 
from the RNA extracted by the Taq-Man one-step quan-
titative real time PCR (RRT-PCR) using the primers and 
probe described in Additional file 1 [25]. One-step RRT-
PCR master mix reagents (Applied Biosystems, Foster 
City, CA, USA) were used following the manufacturer’s 
instructions using 5 μL of eluted RNA in a total volume 
of 25  μL. The amplification conditions were as follows: 
reverse transcription at 48  °C for 30  min; initial dena-
turation reaction at 95 °C for 15 min and 40 PCR-cycles 
of 95 °C 15 s, and 60 °C 1 min. Reaction was performed 
using Fast7500 equipment (Applied Biosystems). Sam-
ples with a Ct value ≤40 were considered positive for 
influenza viral RNA detection.
Viral RNA detection from different lung anatomic 
compartments was extracted using the miRNeasy FFPE 
Kit (no. 217504, Qiagen, Valencia, CA, USA) and the 
RNA stabilisation and on-column DNase digestion pro-
tocols (Qiagen), following the manufacturer’s instruc-
tions. Briefly, the transfer film with the attached dissected 
material, per animal and lung compartment, was placed 
in deparaffinization melting buffer at 72  °C for 10  min, 
and then treated with Proteinase K at 60  °C for 45 min. 
Isolated RNA was concentrated using ethanol precipita-
tion method and membrane column attachment. RNA 
was eluted twice in 14  μL total DEPC water, yielding 
between approximately 5 and 9 ng/μL of RNA, per sam-
ple. RNA extracts were stored at −80  °C until required. 
Reverse transcription was performed using an ImProm-
II reverse transcription system, with random primers 
(Promega, Madison, WI, USA), using 10 µL of the eluted 
RNA. IAV M gene was then quantified on the RNA, 
extracted by two-step RRT-PCR using the forward and 
reverse primers for detection of the M gene, described in 
Additional file 1. Briefly, RRT-PCR was performed using 
a Power SYBR green kit, (Applied Biosystems) and Fast 
7500 equipment (Applied Biosystems). PCR reactions 
were performed in 10  μL reaction volumes, in quad-
ruplicates; 45 amplification cycles were used, and the 
annealing temperature was 60  °C. Results are expressed 
as inverted Ct values. Samples with a Ct value ≤45 were 
considered positive for influenza viral RNA detection.
Gene expression profiles
Total RNA was isolated from LCM tissues, using the 
miRNeasy FFPE Kit (no. 217504, Qiagen), as described in 
the above section.
Relative mRNA expression levels of IFNα, IL-6, 
TLR-3, IL-8, RIG-I, IFNγ, TNFα, CCL2, CCL3 and the 
housekeeping gene β-actin, at each different lung com-
partment, were assessed by two-step RRT-PCR. Primer 
sequences and source are illustrated in the Additional 
file 1. Amplicon sizes of the target genes range between 
90 and 120 base pairs. Briefly, RRT-PCR was performed 
using a Power SYBR green kit (Applied Biosystems) and 
Fast 7500 equipment (Applied Biosystems). RNA extrac-
tion was performed on the ferret lung tissue samples with 
an RNeasy Mini Kit (Qiagen), using the RNA stabiliza-
tion and on-column DNase digestion protocols (Qiagen). 
Reverse transcription was performed using an ImProm-
II reverse transcription system (Promega, Madison, WI, 
USA), at 0.5 µg RNA. PCR reactions were performed in 
10 µL reaction volumes in quadruplicates; 45 amplifica-
tion cycles were used, and the annealing temperature was 
60  °C. The expression levels were normalized using the 
house-keeping gene β-actin using the relative standard 
Figure 1 Laser microdissected lung areas of a pH1N1 infected ferret, at 3 dpi. A Before laser microdissection, B after laser microdissection.
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curve method and taking into account primer efficiency. 
The results are expressed as arbitrary units.
Vascular gene expression
Relative mRNA expression levels of selectin P-ligand 
(SELPLG), and the housekeeping gene β-actin in the 
vascular compartment, were assessed by two-step RRT-
PCR, as described in the above section. Briefly, RRT-PCR 
was performed using a Power SYBR green kit (Applied 
Biosystems) and Fast 7500 equipment (Applied Biosys-
tems). PCR reactions were performed as described in the 
above section and primer sequences and the GenBank 
accession number are illustrated in Additional file 1. The 
expression levels were normalized using the house-keep-
ing gene β-actin using the relative standard curve method 
and taking into account primer efficiency. The results are 
expressed as arbitrary units. Primer sequences for the 
SELPLG gene was designed as described previously [26]. 
The ferret-specific SELPLG gene is available in the NCBI 
nucleotide database [27]. The amplification product was 
detected by electrophoresis to validate the size of the 
product, in accordance with the primer design, and the 
products were purified using a QIAquick PCR Purifica-
tion Kit (Qiagen). Sequencing reactions were performed 
with ABI Prism BigDye Terminator Cycle Sequencing 
v.3.1 Ready Reaction (Applied Biosystems), and analysed 
using an ABI PRISM model 3730 automated sequencer 
(Applied Biosystems). The amplified sequence correlated 
with the ferret specific target sequences.
Statistical analysis
Data visualization was performed with GraphPad Prism 
6 (GraphPad Software, La Jolla, CA, USA). All statistical 
analysis was performed using SPSS 15.0 software (SPSS 
Inc., Chicago, IL, USA). For all analysis, ferret was used 
as the experimental unit. The significance level (α) was 
set at 0.05. The Shapiro–Wilk’s and the Levene test were 
used to evaluate the normality of the distribution of the 
examined quantitative variables, and the homogeneity of 
variances, respectively. No continuous variable that had a 
normal distribution was detected. Thus, a non-paramet-
ric test (Wilcoxon test) using the U Mann–Whitney test 
was used to compare the different values obtained for all 
the parameters (histopathology and viral load), between 
groups (control versus infected), and between different 
compartments of the infected group (alveolar, bronchi-
olar and vascular), for viral load and gene expression pro-
files, at all sampling times.
Results
Histopathology
Histopathological evaluation identified lesions mainly 
localized in bronchial/bronchiolar and alveolar areas 
(Figure  2). At 12  hpi, histopathological lesions were 
characterised by mild bronchiolitis, consisting of bron-
chial/bronchiolar epithelium necrosis, and the presence 
of a mild macrophagic infiltrate in the bronchial/bron-
chiolar lumen. Lesions were similar in both cranial and 
caudal pulmonary lobes at this stage. At 24 hpi, lesions 
were consistent with bronchointerstitial pneumonia, 
or, interstitial pneumonia in the caudal lobes. Bronch-
ointerstitial pneumonia was characterised by bronchial/
bronchiolar necrosis and alveolar epithelial necrosis, 
lymphoplasmacytic infiltration, with mucus and cell 
debris filling the bronchioli and the adjacent alveoli. 
In addition, two of the three animals presented acute 
interstitial pneumonia (DAD) in caudal lobes, at this 
time point.
As expected, after infection, inflammation affected 
firstly the bronchioli (bronchiolitis) at 12  hpi followed 
by extension to surrounding alveoli (bronchointer-
stitial pneumonia) at 24 and 72  hpi. However, some 
animals developed a more extended inflammation of 
alveolar septa (DAD) at 24  hpi. DAD was characterised 
by a moderate to severe bronchiolar necrosis with lym-
phoplasmacytic infiltration in the lamina propria, and a 
variable number of macrophages and neutrophils in the 
lumen. Vascular and alveolar oedema was also observed 
accompanied by inflammatory infiltrates in alveolar and 
perivascular areas. The alveolar septa were also con-
gested, and presented necrosis of type-1 pneumocytes 
cells accompanied by interstitial inflammatory infiltrates 
in the septa and lumen, mainly characterised by mac-
rophages and neutrophils. At 72 hpi, lesions were milder 
than at 24  hpi and consisted of mild bronchointerstitial 
pneumonia.
Higher histopathological scores were observed in the 
infected group in comparison with the control group, 
which did not present any histopathological lesion. 
Of infected animals, lower histopathological scores 
were observed at 12  hpi, while higher histopathological 
scores were observed at 24  hpi. At 72  hpi, histopatho-
logical scores slightly decreased in comparison to 24 hpi 
(Figure 3).
Viral detection and quantification
Viral detection and quantification by IHC was performed 
in lung tissues. In general, viral antigen was observed in 
the nucleus of bronchial and bronchiolar epithelial and 
glandular cells of infected animals at 12 hpi (Figure 2).
At 24  hpi, IAV antigen was observed in the nucleus 
of the respiratory epithelium (bronchial, bronchiolar 
and alveolar), and in the nuclei and cytoplasm of mac-
rophages. In the alveolar epithelium, positive reaction 
was mainly observed in type II pneumocytes, but also in 
type I pneumocytes (Figure 2).
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Quantification of IAV positive cells in the lungs 
of infected animals revealed that higher numbers of 
positive cells were observed in bronchiolar areas at 
12  hpi. Statistically, significant higher numbers of 
positive cells in bronchial areas were observed in com-
parison with alveolar areas at 12 and 72 hpi (Figure 3) 
(p < 0.05).
Viral RNA detection by RRT-PCR in the total lung, and 
in the different lung compartments, and viral titration by 
PFU in the total lung was performed. Control animals 
were negative to viral titration and to viral RNA detection 
in the total lung, and in the different lung compartments 
(Figure 3). In the total lung, higher viral RNA detection 
was observed at 12 and 24 hpi, and then levels decreased 
at 72 hpi. Viral RNA detection in the different anatomic 
compartments of infected animals, showed higher viral 
RNA levels in bronchiolar and alveolar areas at 24  hpi, 
followed by 12 hpi. Vascular areas showed higher levels 
of viral RNA in comparison to control animals, at all-
time points.
Viral titration in the total lung showed higher viral 
titers at 12  hpi, which decreased to similar levels at 24 
and 72  hpi. Viral secretion on nasal swabs was only 
observed in animals at 72 hpi (Figure 3).
Gene expression profiles
Innate immune gene expression levels observed in the 
different anatomic lung compartments are represented 
in (Figure 4). Innate immune gene expression levels were 
higher in all anatomical compartments, in comparison 
with control animals.
Higher levels of IL-6 and TNFα gene expression were 
observed in bronchiolar areas, in comparison with alve-
olar and vascular areas along the experimental period. 
IL-6 gene expression levels were higher at 12  hpi while 
the highest TNFα levels were detected at 24 hpi.
Higher IL-8, CCL3 and CCL2 gene expression lev-
els were observed at 24  hpi. IL-8 and CCL3 were more 
expressed in bronchiolar areas, while CCL2 was more 
expressed in vascular areas. Regarding the IFN response, 
IFNα gene expression levels were higher in bronchiolar 
areas at early stages post-infection (12  dpi), while IFNγ 
was highly expressed also at bronchiolar areas, but in 
later stages of infection (24 and 72  hpi). Interestingly 
after bronchiolar expression, high levels of IL-6 and 
IFNγ were also observed in alveolar and vascular areas 
at 12 and 24 hpi. Besides, a higher expression of IL-8 in 
alveolar areas was observed at 12  hpi. With regard to 
PRRs expression, RIG-I gene was very highly expressed 
Figure 2 Pulmonary histopathological lesions in pH1N1-infected ferrets at different times post infection. Pictures show healthy lung 
sections, and different severity of lesions in alveolar and bronchiolar areas, and the distribution of viral antigen in the respective areas. Each picture 
shows the representative histopathological lesions observed in control animals previous to infection, and in infected animals, at each time post 
infection (three animals evaluated per time-point). HE and immunohistochemical staining for IAV NP antigen (×20 objective field).
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r in bronchiolar areas at 24  hpi, while no major differ-
ences in expression were observed in alveolar or vascular 
areas throughout infection. In contrast, TLR3 was highly 
expressed in all the compartments, but significantly in 
alveolar and vascular areas at 24 hpi.
Vascular gene expression
Vascular adhesion was evaluated by the expression of 
SELPLG gene in vascular areas. Infected animals showed 
higher levels of SELPLG gene expression when compared 
to control animals. SELPLG expression was upregulated 
throughout the infection (see Additional file 2).
Discussion
Three main mechanisms are suggested to be involved 
in pH1N1 pathogenicity: (i) alveolar epithelial necro-
sis, caused by viral cytopathogenicity, and the release 
of cytokines by infected cells; (ii) activation of lung 
Figure 3 Histopathological scores, IAV antigen quantification by IHC and viral RNA detection by RRT-PCR in the lungs. A Histopatho-
logical scores representing lung lesion severity in infected and control (C-) animals. B Immunohistochemical cell quantification of IAV-positive cells 
in infected and control ferret lungs; results express the mean cell counts with SEM (×20 objective field). C IAV RRT-PCR in the total lung of infected 
and control animals and D in different lung compartments of infected and control animals. Values represented as inverted Ct values. E Lung viral 
titration. Values represented as PFU/g. F Nasal swab viral titration. Values represented as PFU/µL. The data expresses the means with SEMS. Statisti-
cally significant differences are represented by *p < 0.05.
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vasculature, which increases endothelial permeability, 
releases cytokines, and triggers leukocyte migration; and 
(iii) damage triggered by the inflammatory infiltrates, 
mainly formed by neutrophils and macrophages, plus the 
release of cytokines from these cells [10]. These mecha-
nisms work in a feed forward manner, eventually increas-
ing the inflammatory damage produced.
In this study, inflammation was firstly observed in 
bronchiolar compartments, in association with viral 
replication in bronchiolar epithelial cells and the higher 
expression of IFNα and IL-6, early after infection. These 
findings were expected, since the bronchiolar epithe-
lium is one of the first targets after IAV infection [10, 
28]. Later, more severe histopathological lesions were 
observed in correspondence with higher presence of 
leukocytes and the infection of alveolar epithelial cells. 
Concurrently, bronchiolar areas presented the higher 
expression of TNFα, CCL3, IL-8 and IFNγ. Alveolar areas 
were also shown to contribute to the influx of inflamma-
tory cells by the up-regulation of IFNα, IL-6 and IL-8, at 
12 hpi, and CCL3 and IFNγ, at 24 hpi. The up-regulation 
of IL-8, IFNγ and CCL3 has been related to lung recruit-
ment of neutrophils, NK and T cells and the development 
of severe influenza infection [8, 14, 19, 29]. In addition, 
TNFα and IL-6 up-regulation mediate phagocytic inflam-
matory infiltration and the apoptosis of infected cells 
[10, 30], which has also been associated with severe lung 
lesions after IAV [7, 11, 31]. Our results indicate that 
early infection of bronchiolar epithelial cells followed by 
alveolar epithelial cells are the primary source of inflam-
matory mediators and contribute to the severity of the 
lung lesion after IAV infection.
Several studies have pointed to the protective role of 
IFNα release after IAV and other viral infections [32–
35]. Here, IFNα was highly upregulated in bronchiolar 
areas in association with the presence of IAV antigen 
detected by IHC in bronchiolar epithelial cells. In con-
trast, the expression of this cytokine in alveolar areas was 
not as relevant as in the bronchiolar compartment, even 
though viral replication was extensive in the alveolar 
compartment at 24 hpi. This differential IFNα expression 
observed in the lung compartments might reflect diverse 
intracellular signalling pathways in different cell types, 
with distinct physiological functions (bronchiolar epi-
thelial cell versus pneumocyte). In that sense, the PRRs 
TLR3 and RIG-I were also up-regulated differently in the 
Figure 4 Innate immune gene expression by RRT-PCR in vascular, bronchiolar, and alveolar areas in the lungs. Comparisons of the gene 
expression levels of IFNα, IL-6, TLR3, IL-8, RIG-I, TNFα, CCL3, IFNγ and CCL2, in different anatomic lung compartments of control (C-) and infected fer-
rets at 12, 24, and 72 hpi. The data expresses the mean with the SEMs. No statistically significant differences were observed between groups.
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lung compartments studied, which may indicate that the 
different cell types recognise viral incursions and acti-
vate the release of cytokines through different signalling 
pathways.
In bronchiolar areas, the up-regulation of different 
immune mediators was associated to a strong up-regula-
tion of RIG-I. RIG-I is activated by the detection of viral 
RNA in replication and its activation has been associated 
with protective and enhanced T cell responses against 
infection and the induction of IFN responses [8, 36].
In contrast to bronchiolar areas, vascular and alveolar 
areas presented a higher induction of TLR3 but did not 
show up-regulation of RIG-I at any time point. After IAV 
infection, TLR3 recognizes infected cells and induces an 
antiviral state that recruits damage-inducing inflamma-
tory cells contributing to lung pathology [14]. Different 
studies reported that TLR3 up-regulation was associated 
with a higher induction of different pro-inflammatory 
molecules, such as CCL2, particularly in vascular areas 
[14]. The detrimental role of CCL2 in IAV pathogen-
esis was proven in a study where CCR2 deficient mice 
infected with IAV inhibited macrophage migration to 
the lungs, increasing survival rates [35, 37]. Other stud-
ies have also associated CCL2 upregulation with poorer 
outcomes of infection [10, 11, 38–40]. In our study, vas-
cular areas showed most of CCL2 expression, particularly 
at 24 hpi, when leukocyte migration was most observed. 
In addition to CCL2, a higher up-regulation of IL-6 and 
IFNγ was also observed at 24 hpi in vascular areas, which 
expression has also been related with severe pathol-
ogy after IAV infection [10]. These data establish a link 
between TLR3 signalling and the activation of endothe-
lial and alveolar epithelial cells, leading to the release of 
different pro-inflammatory mediators, after IAV infec-
tion. In the present study, viral active replication was 
not observed in vascular areas and only low viral antigen 
was detected by IHC in alveolar areas at early stages of 
infection, when TLR3 was highly upregulated. TLR3 is 
expressed in the endosomal compartments of various 
cellular types, whose activation is mediated by the recog-
nition of double stranded RNA (dsRNA), entered into the 
cell by endocytosis [20, 21, 41, 42]. Since dsRNA is a uni-
versal pathogen-associated molecular pattern (PAMP), 
it has been assumed that TLR3 would play a key role in 
antiviral immunity. However, it has been demonstrated 
that TLR3 also contributes to pulmonary damage through 
the induction of pro-inflammatory molecules and the 
recruitment of leukocytes, during IAV virus infection [7, 
42–46]. Furthermore, TLR3 polymorphisms have been 
shown to be related to severe cases of influenza infec-
tion in humans and mice [42, 47, 48] and its upregulation 
has been associated with severe pulmonary lesions in the 
ferret model after IAV infection [42, 46–49]. Moreover, it 
is known that TLR3 signalling is not required for the ini-
tial cell-autonomous recognition of viral infection or the 
induction of IFNα, which is induced via viral recognition 
by RIG-I [50]. These data support the results observed 
in this study and suggests that viruses actively replicat-
ing in the cytoplasm are recognized by RIG-I, but not 
TLR3, irrespective of their route of entry [50]. Besides, 
it has been proved that influenza virus-infected cells do 
not generate dsRNA [51], due to the activity of the cellu-
lar RNA helicase UAP56 [52]. Therefore, we hypothesize 
that TLR3 may recognize unidentified RNA structures, 
from dying influenza virus-infected cells (cell-derived 
extracellular RNA or eRNA), or viral components from 
non-replicative viruses. Supporting this hypothesis, rep-
lication-deficient IAV, arisen from internal deletions of 
IAVs, significantly activated endothelial lung cells induc-
ing a strong host cell response [52]. Besides, it has been 
recently proved, in  vitro and in  vivo, that various types 
of non-self eRNA can be sensed by recipient cells dur-
ing infection, inducing the release of pro-inflammatory 
cytokines from recipient cells [17, 53–55].
In summary, our data points to the role of the respira-
tory bronchiolar epithelium as the first source of pro-
inflammatory cytokines and the influx of phagocytic cells 
into the lungs, early after IAV infection, through the acti-
vation of RIG-I. In addition, alveolar and vascular areas 
contributed to the induction of the pro-inflammatory 
innate immune response, through the activation of TLR3. 
In vascular areas, this activation was observed to be inde-
pendent of active viral replication. We hypothesize that 
the innate immune response induced by vascular areas, 
may be consequence of signals triggered by the detection 
of viral RNA, or, through a complex crosstalk mechanism 
with the infected lung epithelium.
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